Episode

Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma

Podcast: Neuro-Oncology: The Podcast
Published: May 30, 2026
Duration seconds: 199
Processing state: not_requested
Canonical source: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma
Audio: https://traffic.libsyn.com/secure/soc-neuro-onc/nop-139.mp3?dest-id=2339594
JSON: /v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma
Markdown: /podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma.md

Actions

POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-gt-20-phase-1-trial-personalized-neoantigen-dna-vaccine-for-mgmt-unmethylated-glioblastoma.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Host/Interviewee: ç, PhD Candidate, UT Health San Antonio Description: Shahad Abdulsahib discusses the GT-20 phase 1 clinical trial evaluating GNOS-PV01, a personalized multivalent neoantigen DNA vaccine administered following surgical resection and radiation in patients with MGMT unmethylated glioblastoma, with findings published in Nature Cancer on May 12th, 2026.